Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P80404 (
GABA transaminase
)
786
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of apomorphine and bromocriptine on GABA content,
GAD
and
GABA-T
activities in the chick retina, both in conditions of a light cycle of 12 h/day and in conditions of light deprivation for 72 h, were studied. In addition, the effects of a treatment with 2 neuroleptics, having a different action on dopamine receptors, i.e. haloperidol and sulpiride, on the same biochemical parameters were examined. The present results show that all the pharmacological manipulations at the dopaminergic transmission by means of agonists and antagonists at dopamine receptors did not affect GABAergic mechanisms in the chick retina and seem to suggest a lack of relations between dopaminergic and GABAergic mechanisms at this level.
...
PMID:Lack of relation between dopaminergic and gabaergic mechanisms in chick retina. 613 47
Uptake, synthesis, storage, and release of gamma-aminobutyric acid (GABA) are some of the characteristic properties of GABA-ergic neurons. In the present study, we have used these properties as physiological probes to follow the emergence and maturation of GABA-ergic neurons during postnatal development of the rabbit retina. There is autoradiographic, immunocytochemical, and pharmacological evidence that some amacrine cells and certain neurons in the ganglion cell layer probably use GABA as the neurotransmitter. These neurons take up GABA, contain the GABA-synthesizing enzyme L-glutamic acid decarboxylase (
GAD
, EC 4.1.1.15), and release the accumulated GABA by a CA++-dependent mechanism when depolorized with high extracellular K+ concentration. In this study, we show that certain neurons in the newborn retina already possess a specific mechanism for GABA uptake. The positions and numbers of these cells in the developing retina suggest that they will become GABA-ergic neurons in the adult retina. These putative GABA-ergic neurons are, however, probably immature at birth because newborn retinas contain only low levels of GABA and
GAD
. Additionally, there is relatively little K+-stimulated, Ca++-dependent release of (3H)-GABA from the newborn retinas. GABA concentrations and
GAD
activities in developing retinas increase steadily postnatally, reaching about 80% of the adult levels by day 9. The activities of the GABA-degrading enzyme, GABA-glutamate transaminase (
GABA-T
, EC 2.6.1.19), follow a similar pattern of maturation during retinal development. K+ stimulated GABA release, however, remains low until about day 6, and then increases dramatically from 20% to 85% of the adult level over the next 3 days. Taken together, our results indicate that in the rabbit retina, the commitment by certain neurons to use GABA as the transmitter is made prenatally. These neurons are immature at birth but are biochemically, physiologically, and probably functionally mature by about 9 days after birth.
...
PMID:Postnatal development of GABA-ergic neurons in the rabbit retina. 625 33
The effect of anticonvulsant drugs was examined on brain GABA levels and
GAD
and
GABA-T
activities. The level of GABA was increased by the treatment with diphenylhydantoin. The drug had no effect on
GABA-T
activity, whereas
GAD
activity was inhibited. Carbamazepine increased the GABA level but did not effect
GAD
and
GABA-T
activities. Diazepam had no effect on GABA level and
GAD
activity, whereas it caused a slight inhibition of
GABA-T
activity. Phenobarbital administration decreased GABA level only at the higher concentration. Clonazepam effected only
GAD
activity. Some anticonvulsant drugs generally increase brain GABA level; however the lack of correlation with an effect on the
GAD
and
GABA-T
activities indicate that other factors than metabolism, such as membrane transport processes, are involved in the mechanism of action of anticonvulsant drugs.
...
PMID:Effects of some anticonvulsant drugs on brain GABA level and GAD and GABA-T activities. 642 60
The distribution of VPA has been investigated in several brain areas of the rat, and GABA increases were measured. A biphasic exponential decay was observed for VPA; the slowest decrease was noted in the olfactory bulbs and in the hypothalamus where
GAD
and
GABA-T
activities were the highest. The data may be correlated with the prolonged effect of VPA in these areas.
...
PMID:Distribution of sodium valproate and GABA metabolism in CNS of the rat. 644 8
Various biochemical characteristics of the developing GABA system was studied in rats from 1 to 60 days of age. Endogenous GABA concentrations were high in the limbic system, midbrain, brain stem and spinal cord at birth. Until 7 days of postnatal age, GABA concentrations generally decreased, thereafter an increase was seen and at 60 days of age the GABA concentrations exceeded those found in the neonate except for the spinal cord regions. After
GABA-T
inhibition with AOAA, GABA concentrations increased in all brain regions, however considerably more marked in the 28 days old rats compared to the 4 days old animals. Turnover rate of GABA was estimated by investigating the rate of disappearance of GABA after
GAD
inhibition with 3-MPA. Calculated turnover time of whole brain GABA was 34.1 min in the 4 days old rats and 19.9 min in the 28 days old animals. The results from this investigation clearly indicate a caudal to rostral maturational gradient in the development of endogenous GABA concentrations as well as synthesis capacity. Furthermore, turnover rate of total whole brain GABA but probably not of GABA in the neuronal pool is retarded in the 4 days old rats compared to the adolescent animals.
...
PMID:Central GABA mechanisms during postnatal development in the rat: neurochemical characteristics. 672 16
Sodium valproate was injected acutely (400 mg/kg i.p.) into naive and ethanoloamine-O-sulphate chronically pretreated rats and mice, in an attempt to gain further insight into the effects of this anticonvulsant on GABA metabolism. Sodium valproate significantly enhanced the activity of
GAD
in the medulla and pons, cerebellum and midbrain regions of rats, and partially relieved the suppression of
GAD
activity caused by chronic GABA-transaminase inhibition in whole mouse brain. In combination with EOS, sodium valproate caused behavioural excitation in mice which was similar to that sometimes seen with high doses of some
GABA-T
inhibitors. Pretreatment with EOS potentiated the characteristic abstinence behaviour caused by sodium valproate in rats, though no further significant rise in cerebral GABA levels was observed. In view of the neuronal location of
GAD
, the elevation of cerebral GABA levels at least in part by potentiation of
GAD
activity could be involved in the mediation of the anticonvulsant activity of sodium valproate.
...
PMID:The effects of sodium valproate on gamma-aminobutyrate metabolism and behaviour in naive and ethanolamine-O-sulphate pretreated rats and mice. 681 85
1. The kinetic profile of sodium valproate (VPA) and the GABA levels were studied in discrete brain areas of the rat after an i.p. injection of 200 mg/kg. The results were discussed comparatively with
GABA-T
and
GAD
activities reported in the literature. 2. VPA was rapidly distributed in brain areas; its concentrations, its kinetic parameters and the GABA levels after the drug administration were not uniform in the different brain areas studied. 3. The results showed a particular relation of the VPA to the olfactory bulbs; in this specific area the VPA effect on GABA level was stronger; the VPA apparent half life of elimination was longest; the VPA apparent disappearance rate constant was smallest; the initial GABA level was higher; the activities of
GABA-T
and
GAD
were higher than in other brain areas studied except the hypothalamus. 4. These data were correlated with the role of the olfactory bulbs in the behaviour of the rodents.
...
PMID:Sodium valproate: kinetic profile and effects on GABA levels in various brain areas of the rat. 681 13
Alteration of metabolism of taurine in prolonged light- and dark-adapted frog retinae were studied in comparison with that of gamma-aminobutyric acid (GABA) and the following results were obtained. (1) Statistically significant alterations in retinal taurine, an increase in dark-adapted, and a decrease in light-adapted states, respectively, occurred when frogs were adapted continuously to light or dark for more than 3 weeks. Under the same experimental conditions, no alteration in retinal GABA was noted. (2) At 3 weeks and thereafter, a significant increase of retinal cysteine sulfinic acid decarboxylase (CSD; EC 4.1.1.12) activity, an enzyme involved in the biosynthetic pathway of taurine, also occurred in the dark, whereas the activity in the light-adapted retina was reduced. On the other hand, the retinal activity of L-glutamate decarboxylase (
GAD
; EC 1.1.1.15), the rate-limiting enzyme of GABA biosynthesis, was not altered in dark- as well as light-adapted state. Similarly, retinal GABA-transaminase (
GABA-T
; EC 2.6.1.19)-succinic semialdehyde dehydrogenase (SSADH; EC 1.2.1.16) was unaltered. (3) These alterations in retinal taurine were, however, unaccompanied by any changes in factors related to transmitter actions such as evoked release, high affinity uptake, and specific binding to synaptic membranes. The above results suggest that, different from GABA as a potent candidate for inhibitory neurotransmitter, retinal taurine may act as neuromodulator and/or may play an important role as a basic factor for maintaining cellular integrity under certain pathophysiological conditions.
...
PMID:Alteration of metabolism of retinal taurine following prolonged light and dark adaptation: a quantitative comparison with gamma-aminobutyric acid (GABA). 697 81
In young chicks the effects of two different doses of apomorphine, a small dose, producing behavioural and electrocortical sleep and a larger one producing arousal, on GABA content,
GAD
and
GABA-T
activities in the paleostriatum augmentatum were studied. The small dose of apomorphine did not affect GABAergic mechanisms in this area, whereas the dose producing behavioural and electrocortical arousal significantly increased
GAD
activity and GABA content. The results of the present experiments are in favour of an interaction between dopaminergic and GABAergic mechanisms in the avian paleostriatum augmentatum.
...
PMID:Effects of apomorphine on glutamate decarboxylase activity in chick paleostriatum augmentatum. 714 38
The crude mitochondrial fraction of rat brain contains an active dehydrogenase involved in the direct oxidation of gamma-aminobutyric acid. INT (p-iodonitrotetrazolium violet) can serve as an efficient acceptor of electrons in this dehydrogenase reaction. During this oxidation of GABA, ammonia is not produced. In vitro the dehydrogenase activity is inhibited by certain MAO inhibitors. The effects of various inhibitors of
GABA-T
and
GAD
were also investigated. The dehydrogenase activity was found to be susceptible to various anti-convulsants and inhibitors of electron transport. The co-factors which may be involved in the transfer of electrons during GABA oxidation in the presence of INT are also discussed.
...
PMID:GABA dehydrogenase activity in rat brain. 715 Mar 50
<< Previous
1
2
3
4
5
6
Next >>